Organization | Bamrasnaradura Infectious Diseases Institute

Bamrasnaradura Infectious Diseases Institute Report issue

Academic/Hospital Phase 2 Phase 4

Founded: Nonthaburi Thailand (1958)

Organization Overview

First Clinical Trial

2004

NCT00703898

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

Bamrasnaradura Infectious Diseases Institute

Active Ingredients

Drugs in Phase 4 Trials (6)

efavirenz (sustiva) (2 trials)

lamivudine (epivir) (1 trial)

lopinavir (Kaletra) (4 trials)

nevirapine (viramune) (3 trials)

ritonavir (Norvir) (3 trials)

tenofovir (viread) (1 trial)

Drugs in Phase 2 Trials (2)

dolutegravir (tivicay) (1 trial)

rifabutin (mycobutin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Coinfection (Phase 2)

HIV Infections (Phase 4)

Tuberculosis (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 9
# of Trial APIs: 8